首页 > 最新文献

中国当代儿科杂志最新文献

英文 中文
[Application of high-throughput drug sensitivity testing in children with relapsed and refractory acute leukemia]. [高通量药物敏感性测试在复发和难治性急性白血病患儿中的应用]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2406014
Wen-Jing Qi, Xue-Ju Xu, Bai Li, Tao Wang, Guang-Yao Sheng, Ping Zhu, Chun-Mei Wang

Objectives: To explore the current application of high-throughput drug sensitivity (HDS) testing in children with relapsed and refractory acute leukemia (RR-AL) and analyze the feasibility of salvage treatment plans.

Methods: A retrospective collection of clinical data from children with RR-AL who underwent HDS testing at the Department of Children's Hematology and Oncology of the First Affiliated Hospital of Zhengzhou University from November 2021 to October 2023 was conducted, followed by an analysis of drug sensitivity results and treatment outcomes.

Results: A total of 17 children with RR-AL underwent HDS testing, including 7 cases of relapsed refractory acute myeloid leukemia and 10 cases of relapsed refractory acute lymphoblastic leukemia. The detection rate of highly sensitive chemotherapy drugs/regimens was 53% (9/17), while the detection rate of moderately sensitive chemotherapy drugs/regimens was 100% (17/17). Among the 17 RR-AL patients with highly and moderately sensitive chemotherapy drugs and regimens, the MOACD regimen (mitoxantrone + vincristine + cytarabine + cyclophosphamide + dexamethasone) accounted for 100%, with the highest inhibition rate for single-agent mitoxantrone (94%, 16/17), and the highest inhibition rate for targeted therapy being bortezomib (94%, 16/17). Nine patients adjusted their chemotherapy based on HDS testing results, with 4 undergoing hematopoietic stem cell transplantation. Four patients achieved disease-free survival, while 5 died. Eight patients received empirical chemotherapy, with 2 undergoing hematopoietic stem cell transplantation; 4 achieved disease-free survival, while 4 died.

Conclusions: HDS testing can identify highly sensitive drugs/regimens for children with RR-AL, improving the rate of re-remission and creating conditions for subsequent hematopoietic stem cell transplantation.

目的探讨高通量药物敏感性(HDS)检测在复发性和难治性急性白血病(RR-AL)患儿中的应用现状,分析挽救治疗方案的可行性:方法:回顾性收集2021年11月至2023年10月期间在郑州大学第一附属医院儿童血液肿瘤科接受HDS检测的RR-AL患儿的临床资料,并对药敏结果和治疗效果进行分析:结果:共有17例RR-AL患儿接受了HDS检测,其中包括7例复发难治性急性髓性白血病患儿和10例复发难治性急性淋巴细胞白血病患儿。高敏化疗药物/方案的检出率为53%(9/17),中敏化疗药物/方案的检出率为100%(17/17)。在17名化疗药物和方案高度敏感和中度敏感的RR-AL患者中,MOACD方案(米托蒽醌+长春新碱+阿糖胞苷+环磷酰胺+地塞米松)占100%,单药米托蒽醌的抑制率最高(94%,16/17),靶向治疗的抑制率最高的是硼替佐米(94%,16/17)。9名患者根据HDS检测结果调整了化疗方案,其中4人接受了造血干细胞移植。4名患者实现了无病生存,5名患者死亡。8名患者接受了经验性化疗,其中2人进行了造血干细胞移植;4人获得无病生存,4人死亡:结论:HDS检测可为RR-AL患儿确定高敏感药物/方案,提高再缓解率,为后续造血干细胞移植创造条件。
{"title":"[Application of high-throughput drug sensitivity testing in children with relapsed and refractory acute leukemia].","authors":"Wen-Jing Qi, Xue-Ju Xu, Bai Li, Tao Wang, Guang-Yao Sheng, Ping Zhu, Chun-Mei Wang","doi":"10.7499/j.issn.1008-8830.2406014","DOIUrl":"10.7499/j.issn.1008-8830.2406014","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the current application of high-throughput drug sensitivity (HDS) testing in children with relapsed and refractory acute leukemia (RR-AL) and analyze the feasibility of salvage treatment plans.</p><p><strong>Methods: </strong>A retrospective collection of clinical data from children with RR-AL who underwent HDS testing at the Department of Children's Hematology and Oncology of the First Affiliated Hospital of Zhengzhou University from November 2021 to October 2023 was conducted, followed by an analysis of drug sensitivity results and treatment outcomes.</p><p><strong>Results: </strong>A total of 17 children with RR-AL underwent HDS testing, including 7 cases of relapsed refractory acute myeloid leukemia and 10 cases of relapsed refractory acute lymphoblastic leukemia. The detection rate of highly sensitive chemotherapy drugs/regimens was 53% (9/17), while the detection rate of moderately sensitive chemotherapy drugs/regimens was 100% (17/17). Among the 17 RR-AL patients with highly and moderately sensitive chemotherapy drugs and regimens, the MOACD regimen (mitoxantrone + vincristine + cytarabine + cyclophosphamide + dexamethasone) accounted for 100%, with the highest inhibition rate for single-agent mitoxantrone (94%, 16/17), and the highest inhibition rate for targeted therapy being bortezomib (94%, 16/17). Nine patients adjusted their chemotherapy based on HDS testing results, with 4 undergoing hematopoietic stem cell transplantation. Four patients achieved disease-free survival, while 5 died. Eight patients received empirical chemotherapy, with 2 undergoing hematopoietic stem cell transplantation; 4 achieved disease-free survival, while 4 died.</p><p><strong>Conclusions: </strong>HDS testing can identify highly sensitive drugs/regimens for children with RR-AL, improving the rate of re-remission and creating conditions for subsequent hematopoietic stem cell transplantation.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1093-1100"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical features and prognosis of children with fungal bloodstream infection following chemotherapy for acute leukemia]. [急性白血病化疗后儿童血液真菌感染的临床特征和预后]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2406021
Kai-Zhi Weng, Chun-Ping Wu, Shu-Quan Zhuang, Shu-Xian Huang, Xiao-Fang Wang, Yong-Zhi Zheng

Objectives: To investigate the clinical features and prognosis of children with fungal bloodstream infection (BSI) following chemotherapy for acute leukemia (AL).

Methods: A retrospective analysis was performed on 23 children with fungal BSI following chemotherapy for AL in three hospitals in Fujian Province, China, from January 2015 to December 2023. Their clinical features and prognosis were analyzed.

Results: Among all children following chemotherapy for AL, the incidence rate of fungal BSI was 1.38% (23/1 668). At the time of fungal BSI, 87% (20/23) of the children had neutrophil deficiency for more than one week, and all the children presented with fever, while 22% (5/23) of them experienced septic shock. All 23 children exhibited significant increases in C-reactive protein and procalcitonin levels. A total of 23 fungal isolates were detected in peripheral blood cultures, with Candida tropicalis being the most common isolate (52%, 12/23). Caspofungin or micafungin combined with liposomal amphotericin B had a relatively high response rate (75%, 12/16), and the median duration of antifungal therapy was 3.0 months. The overall mortality rate in the patients with fungal BSI was 35% (8/23), and the attributable death rate was 22% (5/23).

Conclusions: Fungal BSI following chemotherapy in children with AL often occurs in children with persistent neutrophil deficiency and lacks specific clinical manifestations. The children with fungal BSI following chemotherapy for AL experience a prolonged course of antifungal therapy and have a high mortality rate, with Candida tropicalis being the most common pathogen.

目的研究急性白血病(AL)化疗后真菌血流感染(BSI)患儿的临床特征和预后:方法:对2015年1月至2023年12月期间福建省三家医院收治的23名急性白血病化疗后真菌BSI患儿进行回顾性分析。结果:在所有接受AL化疗的患儿中,真菌性BSI的发生率最高:在所有接受AL化疗的患儿中,真菌BSI的发生率为1.38%(23/1668)。发生真菌性 BSI 时,87%(20/23)的患儿中性粒细胞缺乏超过一周,所有患儿均出现发热,22%(5/23)的患儿出现脓毒性休克。所有23名患儿的C反应蛋白和降钙素原水平均明显升高。外周血培养中共检测到 23 种真菌分离物,其中热带念珠菌是最常见的分离物(52%,12/23)。卡泊芬净或米卡芬净联合两性霉素 B 脂质体的应答率相对较高(75%,12/16),抗真菌治疗的中位持续时间为 3.0 个月。真菌BSI患者的总死亡率为35%(8/23),可归因死亡率为22%(5/23):结论:AL患儿化疗后真菌性BSI通常发生在中性粒细胞持续缺乏的患儿中,且缺乏特异性临床表现。AL化疗后真菌BSI患儿的抗真菌治疗疗程较长,死亡率较高,热带念珠菌是最常见的病原体。
{"title":"[Clinical features and prognosis of children with fungal bloodstream infection following chemotherapy for acute leukemia].","authors":"Kai-Zhi Weng, Chun-Ping Wu, Shu-Quan Zhuang, Shu-Xian Huang, Xiao-Fang Wang, Yong-Zhi Zheng","doi":"10.7499/j.issn.1008-8830.2406021","DOIUrl":"10.7499/j.issn.1008-8830.2406021","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the clinical features and prognosis of children with fungal bloodstream infection (BSI) following chemotherapy for acute leukemia (AL).</p><p><strong>Methods: </strong>A retrospective analysis was performed on 23 children with fungal BSI following chemotherapy for AL in three hospitals in Fujian Province, China, from January 2015 to December 2023. Their clinical features and prognosis were analyzed.</p><p><strong>Results: </strong>Among all children following chemotherapy for AL, the incidence rate of fungal BSI was 1.38% (23/1 668). At the time of fungal BSI, 87% (20/23) of the children had neutrophil deficiency for more than one week, and all the children presented with fever, while 22% (5/23) of them experienced septic shock. All 23 children exhibited significant increases in C-reactive protein and procalcitonin levels. A total of 23 fungal isolates were detected in peripheral blood cultures, with <i>Candida tropicalis</i> being the most common isolate (52%, 12/23). Caspofungin or micafungin combined with liposomal amphotericin B had a relatively high response rate (75%, 12/16), and the median duration of antifungal therapy was 3.0 months. The overall mortality rate in the patients with fungal BSI was 35% (8/23), and the attributable death rate was 22% (5/23).</p><p><strong>Conclusions: </strong>Fungal BSI following chemotherapy in children with AL often occurs in children with persistent neutrophil deficiency and lacks specific clinical manifestations. The children with fungal BSI following chemotherapy for AL experience a prolonged course of antifungal therapy and have a high mortality rate, with <i>Candida tropicalis</i> being the most common pathogen.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1086-1092"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A prospective randomized controlled study on probiotics for the prevention of antibiotic-associated diarrhea in infants and young children]. [关于益生菌预防婴幼儿抗生素相关性腹泻的前瞻性随机对照研究]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2401129
Su-Wei Zhang, Xian Zhi, Meng-Yu Wang, Dong-Lin Shen
<p><strong>Objectives: </strong>To evaluate the preventive effects of <i>Saccharomyces boulardii</i> powder and tetragenous viable <i>Bifidobacterium</i> tablets on antibiotic-associated diarrhea (AAD) in infants and young children.</p><p><strong>Methods: </strong>Children under three years old admitted to the Department of Pediatrics, Affiliated Hospital of Xuzhou Medical University due to non-gastrointestinal infections and requiring antibiotic treatment from July to December 2023 were enrolled. The children were randomly divided into a control group (<i>n</i>=47), a <i>Saccharomyces boulardii</i> group (<i>n</i>=70), and a <i>Bifidobacterium</i> group (<i>n</i>=65) using a random number table method. The control group received antibiotics and symptomatic supportive treatment according to relevant clinical guidelines. In addition to the treatment given to the control group, the <i>Saccharomyces boulardii</i> group and the <i>Bifidobacterium</i> group were respectively administered with <i>Saccharomyces boulardii</i> powder and tetragenous viable <i>Bifidobacterium</i> tablets. Based on the duration of probiotic use (7 days, 14 days, and 21 days), the <i>Saccharomyces boulardii</i> group was further divided into 7 d, 14 d, and 21 d subgroups, and similarly for the <i>Bifidobacterium</i> group. The incidence of AAD and ratio of cocci to bacilli in feces were compared among the groups after treatment.</p><p><strong>Results: </strong>The incidence rate of AAD in both the <i>Saccharomyces boulardii</i> group and the <i>Bifidobacterium</i> group was lower than that in the control group (<i>P</i><0.017). The duration of AAD and the length of hospital stay were shorter in the <i>Saccharomyces boulardii</i> and <i>Bifidobacterium</i> groups compared to the control group (<i>P</i><0.05). In the control group, the ratio of cocci to bacilli in feces on days 7, 14, and 21 was higher than on day 1 (<i>P</i><0.05). Within-group comparisons showed that the ratio of cocci to bacilli in feces on day 14 in the <i>Bifidobacterium</i> 14 d and 21 d groups were lower than on day 1 (<i>P</i><0.05); and the ratios on day 14 in the control group, <i>Saccharomyces boulardii</i> 14 d group, <i>Saccharomyces boulardii</i> 21 d group, <i>Bifidobacterium</i> 14 d group, and <i>Bifidobacterium</i> 21 d group were lower than on day 7 (<i>P</i><0.05). The ratios on day 21 in the control group and the <i>Saccharomyces boulardii</i> 21 d group were lower than on days 7 and 14 (<i>P</i><0.05). Between-group comparisons indicated that on day 7, the ratios of cocci to bacilli in feces in the <i>Saccharomyces boulardii</i> 7 d, 14 d, 21 d groups, and <i>Bifidobacterium</i> 7 d, 14 d, 21 d groups were all lower than in the control group (<i>P</i><0.05); on day 14, the ratios of cocci to bacilli in feces 14 d and 21 d groups were lower than in the control group and the <i>Bifidobacterium</i> 7 d group (<i>P</i><0.05).</p><p><strong>Conclusions: </strong>Both <i>Saccharomyces boulardii
目的评估布拉氏酵母菌粉和四元双歧杆菌片对婴幼儿抗生素相关性腹泻(AAD)的预防效果:方法:选取2023年7月至12月在徐州医科大学附属医院儿科就诊的因非消化道感染而需要抗生素治疗的3岁以下婴幼儿为研究对象。采用随机数字表法将患儿随机分为对照组(47 人)、布拉氏酵母菌组(70 人)和双歧杆菌组(65 人)。对照组根据相关临床指南接受抗生素和对症支持治疗。布拉氏酵母菌组和双歧杆菌组除了接受对照组的治疗外,还分别服用布拉氏酵母菌粉和四源双歧杆菌片剂。根据使用益生菌的时间(7 天、14 天和 21 天),布拉氏酵母菌组又分为 7 天、14 天和 21 天三个亚组,双歧杆菌组也是如此。比较各组治疗后 AAD 的发生率和粪便中球菌与杆菌的比例:结果:布拉氏酵母菌组和双歧杆菌组的AAD发病率均低于对照组(布拉氏酵母菌组和双歧杆菌组与对照组相比,布拉氏酵母菌14 d组和双歧杆菌21 d组的AAD发病率均低于第1天(布拉氏酵母菌14 d组,布拉氏酵母菌21 d组,双歧杆菌14 d组,布拉氏酵母菌21 d组)、双歧杆菌 14 d 组和双歧杆菌 21 d 组均低于第 7 天(布拉氏酵母菌 21 d 组),低于第 7 天和第 14 天(布拉氏酵母菌 7 d 组、布拉氏酵母菌 14 d 组和双歧杆菌 21 d 组均低于第 7 天和第 14 天),低于对照组(双歧杆菌 7 d 组、双歧杆菌 14 d 组和双歧杆菌 21 d 组均低于第 7 天和第 14 天):布拉氏酵母菌和四元双歧杆菌都能有效改善肠道微生物群,预防婴幼儿AAD的发生。与短期治疗相比,适当延长益生菌治疗时间可进一步改善肠道微生物群的结构。
{"title":"[A prospective randomized controlled study on probiotics for the prevention of antibiotic-associated diarrhea in infants and young children].","authors":"Su-Wei Zhang, Xian Zhi, Meng-Yu Wang, Dong-Lin Shen","doi":"10.7499/j.issn.1008-8830.2401129","DOIUrl":"10.7499/j.issn.1008-8830.2401129","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To evaluate the preventive effects of &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; powder and tetragenous viable &lt;i&gt;Bifidobacterium&lt;/i&gt; tablets on antibiotic-associated diarrhea (AAD) in infants and young children.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Children under three years old admitted to the Department of Pediatrics, Affiliated Hospital of Xuzhou Medical University due to non-gastrointestinal infections and requiring antibiotic treatment from July to December 2023 were enrolled. The children were randomly divided into a control group (&lt;i&gt;n&lt;/i&gt;=47), a &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; group (&lt;i&gt;n&lt;/i&gt;=70), and a &lt;i&gt;Bifidobacterium&lt;/i&gt; group (&lt;i&gt;n&lt;/i&gt;=65) using a random number table method. The control group received antibiotics and symptomatic supportive treatment according to relevant clinical guidelines. In addition to the treatment given to the control group, the &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; group and the &lt;i&gt;Bifidobacterium&lt;/i&gt; group were respectively administered with &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; powder and tetragenous viable &lt;i&gt;Bifidobacterium&lt;/i&gt; tablets. Based on the duration of probiotic use (7 days, 14 days, and 21 days), the &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; group was further divided into 7 d, 14 d, and 21 d subgroups, and similarly for the &lt;i&gt;Bifidobacterium&lt;/i&gt; group. The incidence of AAD and ratio of cocci to bacilli in feces were compared among the groups after treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The incidence rate of AAD in both the &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; group and the &lt;i&gt;Bifidobacterium&lt;/i&gt; group was lower than that in the control group (&lt;i&gt;P&lt;/i&gt;&lt;0.017). The duration of AAD and the length of hospital stay were shorter in the &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; and &lt;i&gt;Bifidobacterium&lt;/i&gt; groups compared to the control group (&lt;i&gt;P&lt;/i&gt;&lt;0.05). In the control group, the ratio of cocci to bacilli in feces on days 7, 14, and 21 was higher than on day 1 (&lt;i&gt;P&lt;/i&gt;&lt;0.05). Within-group comparisons showed that the ratio of cocci to bacilli in feces on day 14 in the &lt;i&gt;Bifidobacterium&lt;/i&gt; 14 d and 21 d groups were lower than on day 1 (&lt;i&gt;P&lt;/i&gt;&lt;0.05); and the ratios on day 14 in the control group, &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; 14 d group, &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; 21 d group, &lt;i&gt;Bifidobacterium&lt;/i&gt; 14 d group, and &lt;i&gt;Bifidobacterium&lt;/i&gt; 21 d group were lower than on day 7 (&lt;i&gt;P&lt;/i&gt;&lt;0.05). The ratios on day 21 in the control group and the &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; 21 d group were lower than on days 7 and 14 (&lt;i&gt;P&lt;/i&gt;&lt;0.05). Between-group comparisons indicated that on day 7, the ratios of cocci to bacilli in feces in the &lt;i&gt;Saccharomyces boulardii&lt;/i&gt; 7 d, 14 d, 21 d groups, and &lt;i&gt;Bifidobacterium&lt;/i&gt; 7 d, 14 d, 21 d groups were all lower than in the control group (&lt;i&gt;P&lt;/i&gt;&lt;0.05); on day 14, the ratios of cocci to bacilli in feces 14 d and 21 d groups were lower than in the control group and the &lt;i&gt;Bifidobacterium&lt;/i&gt; 7 d group (&lt;i&gt;P&lt;/i&gt;&lt;0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Both &lt;i&gt;Saccharomyces boulardii","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1108-1114"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Temporal trend of the global prevalence rate of tension-type headache in children and adolescents in 1990-2021]. [1990-2021年全球儿童和青少年紧张型头痛发病率的时间趋势]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2406037
Ling-Zi Yao, De-Nan Jiang, Jing Wu, Guang-Dian Shen, Jin Cao, Si-Qing Cheng, Shi-Yi Shan, Ze-Yu Luo, Jia-Li Zhou, Pei-Ge Song

Objectives: To investigate the prevalence of tension-type headache (TTH) in children and adolescents aged 0-19 years globally in 1990-2021, and to provide a basis for the prevention and treatment of TTH.

Methods: Based on the Global Burden of Disease Study data, the age-standardized prevalence distribution of TTH and its changing trend were analyzed among the children and adolescents aged 0-19 years, with different sexes, age groups, sociodemographic index (SDI) regions and countries/territories.

Results: The age-standardized prevalence rate (ASPR) of TTH in children and adolescents aged 0-19 globally in 2021 was 17 339.89/100 000, which was increased by 1.73% since 1990. The ASPR in females was slightly higher than that in males (1990: 17 707.65/100 000 vs 16 403.78/100 000; 2021: 17 946.29/100 000 vs 16 763.09/100 000). The ASPR in adolescence was significantly higher than that in school-aged and preschool periods (1990: 27 672.04/100 000 vs 10 134.16/100 000; 2021: 28 239.04/100 000 vs 10 059.39/100 000). Regions with high SDI exhibited a higher ASPR than the other regions, with significant differences in prevalence rates across different countries. From 1990 to 2021, there was a slight increase in global ASPR, with an average annual percentage change (AAPC) of 0.06%. Females experienced a smaller increase than males based on AAPC (0.04% vs 0.07%). There was reduction in ASPR in preschool and school-aged groups, with an AAPC of -0.02%, while there was a significant increase in ASPR in adolescence, with an AAPC of 0.07%. ASPR decreased in regions with low-middle and low levels of SDI, with an AAPC of -0.02% and -0.04%, respectively, while it increased in regions with middle SDI, with an AAPC of 0.24%.

Conclusions: There is a consistent increase in the ASPR of TTH in children and adolescents aged 0-19 years globally, with significant differences across sexes, age groups, SDI regions and countries/territories.

目的调查1990-2021年全球0-19岁儿童和青少年紧张型头痛(TTH)的患病率,为TTH的预防和治疗提供依据:方法:根据全球疾病负担研究数据,分析不同性别、年龄组、社会人口指数(SDI)地区和国家/地区的0-19岁儿童和青少年中TTH的年龄标准化患病率分布及其变化趋势:2021年,全球0-19岁儿童和青少年的TTH年龄标准化患病率(ASPR)为17 339.89/100 000,比1990年增加了1.73%。女性的ASPR略高于男性(1990年:17 707.65/100 000 vs 16 403.78/100 000;2021年:17 946.29/100 000 vs 16 763.09/100 000)。青少年期的 ASPR 明显高于学龄期和学龄前期(1990 年:27 672.04/100000 vs 10 134.16/100000;2021 年:28 239.04/100000 vs 10 059.39/100000)。SDI 高的地区显示出比其他地区更高的 ASPR,不同国家的流行率存在显著差异。从 1990 年到 2021 年,全球 ASPR 略有上升,年均百分比变化 (AAPC) 为 0.06%。根据年平均百分比变化率,女性的增幅小于男性(0.04% 对 0.07%)。学龄前和学龄组的 ASPR 有所下降,年均百分比变化率为-0.02%,而青少年组的 ASPR 则显著上升,年均百分比变化率为 0.07%。在 SDI 处于中低水平和低水平的地区,ASPR 有所下降,AAPC 分别为-0.02%和-0.04%,而在 SDI 处于中等水平的地区,ASPR 有所上升,AAPC 为 0.24%:结论:全球 0-19 岁儿童和青少年的全结核病发病率呈持续上升趋势,不同性别、年龄组、SDI 地区和国家/地区之间存在显著差异。
{"title":"[Temporal trend of the global prevalence rate of tension-type headache in children and adolescents in 1990-2021].","authors":"Ling-Zi Yao, De-Nan Jiang, Jing Wu, Guang-Dian Shen, Jin Cao, Si-Qing Cheng, Shi-Yi Shan, Ze-Yu Luo, Jia-Li Zhou, Pei-Ge Song","doi":"10.7499/j.issn.1008-8830.2406037","DOIUrl":"10.7499/j.issn.1008-8830.2406037","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the prevalence of tension-type headache (TTH) in children and adolescents aged 0-19 years globally in 1990-2021, and to provide a basis for the prevention and treatment of TTH.</p><p><strong>Methods: </strong>Based on the Global Burden of Disease Study data, the age-standardized prevalence distribution of TTH and its changing trend were analyzed among the children and adolescents aged 0-19 years, with different sexes, age groups, sociodemographic index (SDI) regions and countries/territories.</p><p><strong>Results: </strong>The age-standardized prevalence rate (ASPR) of TTH in children and adolescents aged 0-19 globally in 2021 was 17 339.89/100 000, which was increased by 1.73% since 1990. The ASPR in females was slightly higher than that in males (1990: 17 707.65/100 000 vs 16 403.78/100 000; 2021: 17 946.29/100 000 vs 16 763.09/100 000). The ASPR in adolescence was significantly higher than that in school-aged and preschool periods (1990: 27 672.04/100 000 vs 10 134.16/100 000; 2021: 28 239.04/100 000 vs 10 059.39/100 000). Regions with high SDI exhibited a higher ASPR than the other regions, with significant differences in prevalence rates across different countries. From 1990 to 2021, there was a slight increase in global ASPR, with an average annual percentage change (AAPC) of 0.06%. Females experienced a smaller increase than males based on AAPC (0.04% vs 0.07%). There was reduction in ASPR in preschool and school-aged groups, with an AAPC of -0.02%, while there was a significant increase in ASPR in adolescence, with an AAPC of 0.07%. ASPR decreased in regions with low-middle and low levels of SDI, with an AAPC of -0.02% and -0.04%, respectively, while it increased in regions with middle SDI, with an AAPC of 0.24%.</p><p><strong>Conclusions: </strong>There is a consistent increase in the ASPR of TTH in children and adolescents aged 0-19 years globally, with significant differences across sexes, age groups, SDI regions and countries/territories.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1058-1065"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Characteristics of early cognitive development in children with Williams syndrome: a prospective cohort study]. [威廉姆斯综合症儿童早期认知发展的特点:前瞻性队列研究]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2404029
Dan Yao, Fang-Fang Li, Ji-Yang Shen, Wei-Jun Chen, Chai Ji

Objectives: To investigate the early cognitive development characteristics of children with Williams syndrome (WS) at different age stages.

Methods: From September 2018 to June 2023, 106 children diagnosed with WS at the Department of Pediatric Health Care, Children's Hospital, Zhejiang University School of Medicine, aged 1 to <5 years, were prospectively enrolled. All children underwent Gesell developmental diagnostic assessments to analyze the cognitive development characteristics of WS children across different age groups.

Results: The average age of the 106 WS children was (3.1±1.2) years; 58 were male, and 48 were female. There were no significant differences in developmental levels between males and females in the five domains of gross motor skills, fine motor skills, language, personal-social skills, and adaptive behavior (P>0.05). The incidence rates of mild, moderate, severe, and profound developmental disabilities among children of different age groups showed no significant differences (P>0.05). Comparisons of developmental levels in gross motor skills, language, personal-social skills, and adaptive behavior among different age groups were also not statistically significant (P>0.05). With the increase of age, the developmental level of fine motor skills showed a decreasing trend (P<0.05). There were no significant differences in verbal IQ and non-verbal IQ within each age group of WS children (P>0.05).

Conclusions: The overall developmental level of WS children stabilizes with age, and their early language abilities do not significantly exceed their non-verbal abilities.

目的:研究威廉姆斯综合症(WS)儿童在不同年龄阶段的早期认知发展特点:研究威廉姆斯综合征(WS)患儿不同年龄阶段的早期认知发育特征:2018年9月至2023年6月,浙江大学医学院附属儿童医院儿保科确诊的106例WS患儿,年龄1~ 结果:106例WS患儿的平均年龄为(3.1±1.2)岁,其中男性58例,女性48例。在大运动技能、精细运动技能、语言、个人-社会技能和适应行为五个领域中,男女发育水平差异无学意义(P>0.05)。不同年龄组儿童的轻度、中度、重度和极重度发育障碍发生率无显著差异(P>0.05)。不同年龄组儿童在粗大运动技能、语言、个人-社会技能和适应行为方面的发育水平比较也无统计学意义(P>0.05)。随着年龄的增长,精细动作技能的发展水平呈下降趋势(PP>0.05):结论:随着年龄的增长,WS 儿童的整体发育水平趋于稳定,他们的早期语言能力并没有明显超过非语言能力。
{"title":"[Characteristics of early cognitive development in children with Williams syndrome: a prospective cohort study].","authors":"Dan Yao, Fang-Fang Li, Ji-Yang Shen, Wei-Jun Chen, Chai Ji","doi":"10.7499/j.issn.1008-8830.2404029","DOIUrl":"10.7499/j.issn.1008-8830.2404029","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the early cognitive development characteristics of children with Williams syndrome (WS) at different age stages.</p><p><strong>Methods: </strong>From September 2018 to June 2023, 106 children diagnosed with WS at the Department of Pediatric Health Care, Children's Hospital, Zhejiang University School of Medicine, aged 1 to <5 years, were prospectively enrolled. All children underwent Gesell developmental diagnostic assessments to analyze the cognitive development characteristics of WS children across different age groups.</p><p><strong>Results: </strong>The average age of the 106 WS children was (3.1±1.2) years; 58 were male, and 48 were female. There were no significant differences in developmental levels between males and females in the five domains of gross motor skills, fine motor skills, language, personal-social skills, and adaptive behavior (<i>P</i>>0.05). The incidence rates of mild, moderate, severe, and profound developmental disabilities among children of different age groups showed no significant differences (<i>P</i>>0.05). Comparisons of developmental levels in gross motor skills, language, personal-social skills, and adaptive behavior among different age groups were also not statistically significant (<i>P</i>>0.05). With the increase of age, the developmental level of fine motor skills showed a decreasing trend (<i>P</i><0.05). There were no significant differences in verbal IQ and non-verbal IQ within each age group of WS children (<i>P</i>>0.05).</p><p><strong>Conclusions: </strong>The overall developmental level of WS children stabilizes with age, and their early language abilities do not significantly exceed their non-verbal abilities.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1053-1057"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Relationship of cerebrospinal fluid and serum levels of SIL-2R, eNOS, and CD93 with the progression and prognosis of viral encephalitis in children]. [脑脊液和血清中 SIL-2R、eNOS 和 CD93 水平与儿童病毒性脑炎病情发展和预后的关系]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2405043
Jie Song, Yi-Lin Wang, Jia-Qi Chu

Objectives: To investigate the relationship of cerebrospinal fluid and serum levels of soluble interleukin-2 receptor (SIL-2R), endothelial nitric oxide synthase (eNOS), and cluster of differentiation 93 (CD93) with the progression and prognosis of viral encephalitis (VE) in children.

Methods: Prospectively, 102 children with VE admitted from January 2021 to January 2024 were selected as the VE group. The patients were divided into a mild subgroup (64 patients) and a severe subgroup (38 patients) according to disease progression. The patients were also divided into a good prognosis subgroup (29 patients) and a poor prognosis subgroup (73 patients) according to prognosis. A control group of 102 children with central nervous system diseases who were examined and found not to have VE during the same period was selected. The factors contributing to the poor prognosis of children with VE and the predictive value of SIL-2R, eNOS, and CD93 in cerebrospinal fluid and serum for the poor prognosis of children with VE were evaluated.

Results: Cerebrospinal fluid and serum SIL-2R, eNOS, and CD93 levels were significantly increased in the VE group, severe subgroup, and poor prognosis subgroup (P<0.05). Multivariate logistic regression analysis showed that high SIL-2R, eNOS, and CD93 levels in cerebrospinal fluid and serum were risk factors for poor prognosis in children with VE (P<0.05). Receiver operating characteristic curve analysis showed that the combination of cerebrospinal fluid SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (P<0.05). Similarly, the combination of serum SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (P<0.05).

Conclusions: The cerebrospinal fluid and serum levels of SIL-2R, eNOS, and CD93 are significantly elevated in children with VE, and they are associated with VE progression and prognosis.

研究目的研究脑脊液和血清中可溶性白细胞介素-2受体(SIL-2R)、内皮一氧化氮合酶(eNOS)和分化簇93(CD93)水平与儿童病毒性脑炎(VE)病情进展和预后的关系:方法:前瞻性地选取2021年1月至2024年1月期间收治的102名VE患儿作为VE组。根据疾病进展情况将患者分为轻度亚组(64 例)和重度亚组(38 例)。根据预后情况,患者还被分为预后良好亚组(29 例)和预后不良亚组(73 例)。对照组为 102 名患有中枢神经系统疾病的儿童,他们在同一时期接受了检查,但未发现 VE。评估了导致 VE 患儿预后不良的因素,以及脑脊液和血清中的 SIL-2R、eNOS 和 CD93 对 VE 患儿预后不良的预测价值:结果:脑脊液和血清中的SIL-2R、eNOS和CD93水平在VE组、重症亚组和预后不良亚组(PPPPConclusions:VE患儿脑脊液和血清中的SIL-2R、eNOS和CD93水平明显升高,它们与VE的进展和预后有关。
{"title":"[Relationship of cerebrospinal fluid and serum levels of SIL-2R, eNOS, and CD93 with the progression and prognosis of viral encephalitis in children].","authors":"Jie Song, Yi-Lin Wang, Jia-Qi Chu","doi":"10.7499/j.issn.1008-8830.2405043","DOIUrl":"10.7499/j.issn.1008-8830.2405043","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the relationship of cerebrospinal fluid and serum levels of soluble interleukin-2 receptor (SIL-2R), endothelial nitric oxide synthase (eNOS), and cluster of differentiation 93 (CD93) with the progression and prognosis of viral encephalitis (VE) in children.</p><p><strong>Methods: </strong>Prospectively, 102 children with VE admitted from January 2021 to January 2024 were selected as the VE group. The patients were divided into a mild subgroup (64 patients) and a severe subgroup (38 patients) according to disease progression. The patients were also divided into a good prognosis subgroup (29 patients) and a poor prognosis subgroup (73 patients) according to prognosis. A control group of 102 children with central nervous system diseases who were examined and found not to have VE during the same period was selected. The factors contributing to the poor prognosis of children with VE and the predictive value of SIL-2R, eNOS, and CD93 in cerebrospinal fluid and serum for the poor prognosis of children with VE were evaluated.</p><p><strong>Results: </strong>Cerebrospinal fluid and serum SIL-2R, eNOS, and CD93 levels were significantly increased in the VE group, severe subgroup, and poor prognosis subgroup (<i>P</i><0.05). Multivariate logistic regression analysis showed that high SIL-2R, eNOS, and CD93 levels in cerebrospinal fluid and serum were risk factors for poor prognosis in children with VE (<i>P</i><0.05). Receiver operating characteristic curve analysis showed that the combination of cerebrospinal fluid SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (<i>P</i><0.05). Similarly, the combination of serum SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (<i>P</i><0.05).</p><p><strong>Conclusions: </strong>The cerebrospinal fluid and serum levels of SIL-2R, eNOS, and CD93 are significantly elevated in children with VE, and they are associated with VE progression and prognosis.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1072-1077"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A case-control study on the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with risk of congenital heart disease in offspring]. [父母围孕期吸烟和饮酒与后代患先天性心脏病风险的关联及其相互作用的病例对照研究]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2404116
Liu-Xuan Li, Man-Jun Luo, Xiao-Rui Ruan, Han-Jun Liu, Jia-Peng Tang, Gui-Hong Yang, Jia-Bi Qin

Objectives: To explore the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with risk of congenital heart disease (CHD) in offspring.

Methods: The parents of children with simple CHD aged 0 to 1 year (n=683) were recruited as the case group, while the parents of healthy children aged 0 to 1 year (n=740) served as the control group. A case-control study was conducted, and a questionnaire was used to collect information on perinatal exposures. After controlling for relevant confounding factors using multivariate logistic regression analysis and propensity score matching, the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with CHD were examined, as well as the cumulative effects of smoking and drinking on CHD risk.

Results: Maternal active smoking (OR=2.91, 95%CI: 1.60-5.30), passive smoking (OR=1.94, 95%CI: 1.56-2.42), and alcohol consumption (OR=2.59, 95%CI: 1.89-3.54), as well as paternal smoking (OR=1.52; 95%CI: 1.22-1.90) and drinking (OR=1.48, 95%CI: 1.19-1.84), were associated with an increased risk of CHD in offspring. There was no interaction between parental smoking and drinking behaviors during the periconceptional period concerning the risk of CHD in offspring (P>0.05). The more parents' smoking and drinking behaviors during the perinatal pregnancy, the higher the risk of CHD in their offspring (OR=1.50, 95%CI: 1.36-1.65).

Conclusions: Parental smoking and alcohol consumption during the periconceptional period are associated with the occurrence of CHD in offspring, and there is a cumulative effect on CHD risk, suggesting that reducing tobacco and alcohol exposure during the periconceptional period may lower the incidence of CHD.

目的探讨父母在围孕期吸烟和饮酒与后代先天性心脏病(CHD)风险的关联及其相互作用:招募0至1岁单纯先天性心脏病患儿的父母(683人)作为病例组,0至1岁健康儿童的父母(740人)作为对照组。研究采用病例对照的方法,通过问卷调查收集围产期暴露的相关信息。在使用多变量逻辑回归分析和倾向得分匹配法控制了相关混杂因素后,研究人员考察了父母在围孕期吸烟和饮酒与先天性心脏病的关联及其相互作用,以及吸烟和饮酒对先天性心脏病风险的累积效应:结果:母亲主动吸烟(OR=2.91,95%CI:1.60-5.30)、被动吸烟(OR=1.94,95%CI:1.56-2.42)和饮酒(OR=2.59,95%CI:1.89-3.54)以及父亲吸烟(OR=1.52;95%CI:1.22-1.90)和饮酒(OR=1.48,95%CI:1.19-1.84)与后代罹患冠心病的风险增加有关。围孕期父母吸烟和饮酒行为与后代罹患冠心病的风险之间不存在交互作用(P>0.05)。父母围孕期吸烟和饮酒行为越多,其后代患先天性心脏病的风险越高(OR=1.50,95%CI:1.36-1.65):父母在围孕期吸烟和饮酒与子代发生冠心病有关,并且对冠心病风险有累积效应,这表明减少围孕期的烟草和酒精暴露可降低冠心病的发病率。
{"title":"[A case-control study on the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with risk of congenital heart disease in offspring].","authors":"Liu-Xuan Li, Man-Jun Luo, Xiao-Rui Ruan, Han-Jun Liu, Jia-Peng Tang, Gui-Hong Yang, Jia-Bi Qin","doi":"10.7499/j.issn.1008-8830.2404116","DOIUrl":"10.7499/j.issn.1008-8830.2404116","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with risk of congenital heart disease (CHD) in offspring.</p><p><strong>Methods: </strong>The parents of children with simple CHD aged 0 to 1 year (<i>n</i>=683) were recruited as the case group, while the parents of healthy children aged 0 to 1 year (<i>n</i>=740) served as the control group. A case-control study was conducted, and a questionnaire was used to collect information on perinatal exposures. After controlling for relevant confounding factors using multivariate logistic regression analysis and propensity score matching, the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with CHD were examined, as well as the cumulative effects of smoking and drinking on CHD risk.</p><p><strong>Results: </strong>Maternal active smoking (<i>OR</i>=2.91, 95%<i>CI</i>: 1.60-5.30), passive smoking (<i>OR</i>=1.94, 95%<i>CI</i>: 1.56-2.42), and alcohol consumption (<i>OR</i>=2.59, 95%<i>CI</i>: 1.89-3.54), as well as paternal smoking (<i>OR</i>=1.52; 95%<i>CI</i>: 1.22-1.90) and drinking (<i>OR</i>=1.48, 95%<i>CI</i>: 1.19-1.84), were associated with an increased risk of CHD in offspring. There was no interaction between parental smoking and drinking behaviors during the periconceptional period concerning the risk of CHD in offspring (<i>P</i>>0.05). The more parents' smoking and drinking behaviors during the perinatal pregnancy, the higher the risk of CHD in their offspring (<i>OR</i>=1.50, 95%<i>CI</i>: 1.36-1.65).</p><p><strong>Conclusions: </strong>Parental smoking and alcohol consumption during the periconceptional period are associated with the occurrence of CHD in offspring, and there is a cumulative effect on CHD risk, suggesting that reducing tobacco and alcohol exposure during the periconceptional period may lower the incidence of CHD.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1019-1026"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Measurement of intrinsic positive end-expiratory pressure and clinical outcomes of infants with severe bronchopulmonary dysplasia]. [严重支气管肺发育不良婴儿的内在呼气末正压测量和临床结果]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2404133
Xin Qin, Xiao-Peng Zhao, Hua-Yan Zhang

Objectives: To investigate the levels of intrinsic positive end-expiratory pressure (PEEPi) in infants with severe bronchopulmonary dysplasia (sBPD) and the relationship between different levels of PEEPi and clinical outcomes.

Methods: A retrospective analysis was conducted on the clinical data of 12 sBPD infants who underwent PEEPi measurement and were hospitalized at Guangzhou Women and Children's Medical Center from January 2022 to June 2023. The clinical manifestations and outcomes at discharge were compared between infants with very high PEEPi (≥10 cmH2O) and those with lower PEEPi (<10 cmH2O).

Results: PEEPi measurements were taken in 12 sBPD infants between gestational age 31+3 and 67+2 weeks postmenstrual age, with the lowest PEEPi measured at 0.9 cmH2O and the highest at 19.6 cmH2O; 50% (6/12) of the infants had PEEPi ≥10 cmH2O. All infants with very high PEEPi exhibited ineffective triggering and patient-ventilator asynchrony. Among them, 5 infants could not be weaned off invasive ventilation, resulting in 4 deaths and 1 infant being discharged with a tracheostomy and ventilator support. In contrast, among the infants with PEEPi <10 cmH2O, only 1 infant died, while the others were successfully extubated and discharged.

Conclusions: Infants with sBPD may have elevated PEEPi levels, and very high PEEPi may be associated with adverse outcomes in these patients.

目的研究重度支气管肺发育不良(sBPD)婴儿内在呼气末正压(PEEPi)的水平,以及不同水平的PEEPi与临床预后的关系:方法:对2022年1月至2023年6月期间在广州市妇女儿童医疗中心住院并接受PEEPi测量的12名sBPD婴儿的临床资料进行回顾性分析。比较了高PEEPi(≥10 cmH2O)和低PEEPi(2O)婴儿的临床表现和出院时的预后:对孕龄 31+3 周至月龄后 67+2 周的 12 名 sBPD 婴儿进行了 PEEPi 测量,测量到的最低 PEEPi 为 0.9 cmH2O,最高为 19.6 cmH2O;50%(6/12)的婴儿 PEEPi ≥10 cmH2O。所有 PEEPi 非常高的婴儿都表现出无效触发和患者与呼吸机不同步。其中,5 名婴儿无法脱离有创通气,导致 4 名婴儿死亡,1 名婴儿带着气管造口和呼吸机支持出院。相比之下,在 PEEPi 为 2O 的婴儿中,只有 1 名婴儿死亡,其他婴儿均成功拔管出院:结论:患有 sBPD 的婴儿可能会出现 PEEPi 水平升高的情况,而极高的 PEEPi 可能与这些患者的不良预后有关。
{"title":"[Measurement of intrinsic positive end-expiratory pressure and clinical outcomes of infants with severe bronchopulmonary dysplasia].","authors":"Xin Qin, Xiao-Peng Zhao, Hua-Yan Zhang","doi":"10.7499/j.issn.1008-8830.2404133","DOIUrl":"10.7499/j.issn.1008-8830.2404133","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the levels of intrinsic positive end-expiratory pressure (PEEPi) in infants with severe bronchopulmonary dysplasia (sBPD) and the relationship between different levels of PEEPi and clinical outcomes.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the clinical data of 12 sBPD infants who underwent PEEPi measurement and were hospitalized at Guangzhou Women and Children's Medical Center from January 2022 to June 2023. The clinical manifestations and outcomes at discharge were compared between infants with very high PEEPi (≥10 cmH<sub>2</sub>O) and those with lower PEEPi (<10 cmH<sub>2</sub>O).</p><p><strong>Results: </strong>PEEPi measurements were taken in 12 sBPD infants between gestational age 31<sup>+3</sup> and 67<sup>+2</sup> weeks postmenstrual age, with the lowest PEEPi measured at 0.9 cmH<sub>2</sub>O and the highest at 19.6 cmH<sub>2</sub>O; 50% (6/12) of the infants had PEEPi ≥10 cmH<sub>2</sub>O. All infants with very high PEEPi exhibited ineffective triggering and patient-ventilator asynchrony. Among them, 5 infants could not be weaned off invasive ventilation, resulting in 4 deaths and 1 infant being discharged with a tracheostomy and ventilator support. In contrast, among the infants with PEEPi <10 cmH<sub>2</sub>O, only 1 infant died, while the others were successfully extubated and discharged.</p><p><strong>Conclusions: </strong>Infants with sBPD may have elevated PEEPi levels, and very high PEEPi may be associated with adverse outcomes in these patients.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1034-1039"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recommendations for antibiotic use in hospitalized preterm infants with late-onset sepsis in the neonatal intensive care unit]. [新生儿重症监护室对患有晚期败血症的住院早产儿使用抗生素的建议]。
Q3 Medicine Pub Date : 2024-10-15 DOI: 10.7499/j.issn.1008-8830.2408024

Late-onset sepsis (LOS) is commonly seen in neonates who are hospitalized for extended periods, particularly in very low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI). Currently, the management of LOS in preterm infants faces dual challenges of delayed diagnosis and treatment, as well as antibiotic overtreatment. To address these issues, the Hunan Neonatal Medical Quality Control Center and the Neonatology Group of Perinatal Medical Committee of Hunan Medical Association organized a group of neonatal experts from Hunan Province to formulate recommendations based on published literature and statistical data from the Hunan Neonatal Medical Quality Control Center, as well as real-world practices in most neonatal intensive care units in Hunan Province. The group of neonatal experts proposed 15 recommendations for the diagnosis and antibiotic treatment of LOS in hospitalized preterm infants in the neonatal intensive care unit.

晚发性败血症(LOS)常见于长期住院的新生儿,尤其是出生体重极轻的婴儿(VLBWI)和出生体重极重的婴儿(ELBWI)。目前,早产儿 LOS 的治疗面临着诊断和治疗延迟以及抗生素过度治疗的双重挑战。针对这些问题,湖南省新生儿医疗质量控制中心和湖南省医学会围产医学专业委员会新生儿学组组织湖南省新生儿专家,根据已发表的文献、湖南省新生儿医疗质量控制中心的统计数据以及湖南省大多数新生儿重症监护室的实际情况,制定了相关建议。新生儿专家组就新生儿重症监护室住院早产儿 LOS 的诊断和抗生素治疗提出了 15 条建议。
{"title":"[Recommendations for antibiotic use in hospitalized preterm infants with late-onset sepsis in the neonatal intensive care unit].","authors":"","doi":"10.7499/j.issn.1008-8830.2408024","DOIUrl":"10.7499/j.issn.1008-8830.2408024","url":null,"abstract":"<p><p>Late-onset sepsis (LOS) is commonly seen in neonates who are hospitalized for extended periods, particularly in very low birth weight infants (VLBWI) and extremely low birth weight infants (ELBWI). Currently, the management of LOS in preterm infants faces dual challenges of delayed diagnosis and treatment, as well as antibiotic overtreatment. To address these issues, the Hunan Neonatal Medical Quality Control Center and the Neonatology Group of Perinatal Medical Committee of Hunan Medical Association organized a group of neonatal experts from Hunan Province to formulate recommendations based on published literature and statistical data from the Hunan Neonatal Medical Quality Control Center, as well as real-world practices in most neonatal intensive care units in Hunan Province. The group of neonatal experts proposed 15 recommendations for the diagnosis and antibiotic treatment of LOS in hospitalized preterm infants in the neonatal intensive care unit.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1009-1018"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Changes and significance of oxidized phospholipids and endothelial nitric oxide synthase in the acute stage of Kawasaki disease]. [川崎病急性期氧化磷脂和内皮一氧化氮合酶的变化及其意义]。
Q3 Medicine Pub Date : 2024-08-15 DOI: 10.7499/j.issn.1008-8830.2403056
Liu-Rong Zhu, Xue-Hua He, Yong-Hua Yuan, Hao Yuan, Xiao-Hui Xia

Objectives: To investigate the changes in the serum levels of oxidized phospholipids (OxPLs) and endothelial nitric oxide synthase (eNOS) and their association with coronary artery disease (CAL) in children in the acute stage of Kawasaki disease (KD), as well as the clinical significance of OxPLs and eNOS.

Methods: A prospective study was conducted on 95 children in the acute stage of KD (KD group). According to the presence of absence of CAL, the KD group was further divided into a CAL subgroup and a non-CAL (NCAL) subgroup. Thirty children with fever due to lower respiratory tract infection were enrolled as the fever group. Thirty healthy children who underwent physical examination were enrolled as the healthy control group. The above groups were compared in terms of general information and serum levels of OxPLs, eNOS and other laboratory indexes, and the correlation between OxPLs level and eNOS level was analyzed.

Results: The KD group had a significantly higher level of OxPLs and a significantly lower level of eNOS compared with the fever group and the healthy control group (P<0.05). After treatment, the children with KD had a significantly decreased OxPLs level and a significantly increased eNOS level (P<0.05). Compared with the NCAL subgroup, the CAL subgroup had a significantly higher level of OxPLs and a significantly lower level of eNOS (P<0.05). Among the children of KD, the level of OxPLs was negatively correlated with that of eNOS (rs=-0.353, P<0.05).

Conclusions: Serum OxPLs and eNOS in the acute stage of KD may be involved in the development of CAL in children with KD, and therefore, they may be used as the biomarkers to predict CAL in these children.

研究目的研究川崎病(KD)急性期患儿血清中氧化磷脂(OxPLs)和内皮一氧化氮合酶(eNOS)水平的变化及其与冠状动脉疾病(CAL)的关系,以及OxPLs和eNOS的临床意义:对95名处于川崎病急性期的儿童(川崎病组)进行了前瞻性研究。根据是否存在 CAL,KD 组又分为 CAL 亚组和非 CAL(NCAL)亚组。30名因下呼吸道感染而发烧的儿童被纳入发烧组。30 名接受体检的健康儿童作为健康对照组。比较上述各组的一般资料和血清中OxPLs、eNOS水平及其他实验室指标,并分析OxPLs水平与eNOS水平的相关性:结果:与发热组和健康对照组相比,KD组的OxPLs水平明显升高,eNOS水平明显降低(PPPrs=-0.353,PConclusions:KD急性期血清OxPLs和eNOS可能参与了KD患儿CAL的发展,因此可作为预测这些患儿CAL的生物标志物。
{"title":"[Changes and significance of oxidized phospholipids and endothelial nitric oxide synthase in the acute stage of Kawasaki disease].","authors":"Liu-Rong Zhu, Xue-Hua He, Yong-Hua Yuan, Hao Yuan, Xiao-Hui Xia","doi":"10.7499/j.issn.1008-8830.2403056","DOIUrl":"10.7499/j.issn.1008-8830.2403056","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the changes in the serum levels of oxidized phospholipids (OxPLs) and endothelial nitric oxide synthase (eNOS) and their association with coronary artery disease (CAL) in children in the acute stage of Kawasaki disease (KD), as well as the clinical significance of OxPLs and eNOS.</p><p><strong>Methods: </strong>A prospective study was conducted on 95 children in the acute stage of KD (KD group). According to the presence of absence of CAL, the KD group was further divided into a CAL subgroup and a non-CAL (NCAL) subgroup. Thirty children with fever due to lower respiratory tract infection were enrolled as the fever group. Thirty healthy children who underwent physical examination were enrolled as the healthy control group. The above groups were compared in terms of general information and serum levels of OxPLs, eNOS and other laboratory indexes, and the correlation between OxPLs level and eNOS level was analyzed.</p><p><strong>Results: </strong>The KD group had a significantly higher level of OxPLs and a significantly lower level of eNOS compared with the fever group and the healthy control group (<i>P</i><0.05). After treatment, the children with KD had a significantly decreased OxPLs level and a significantly increased eNOS level (<i>P</i><0.05). Compared with the NCAL subgroup, the CAL subgroup had a significantly higher level of OxPLs and a significantly lower level of eNOS (<i>P</i><0.05). Among the children of KD, the level of OxPLs was negatively correlated with that of eNOS (<i>r<sub>s</sub></i>=-0.353, <i>P</i><0.05).</p><p><strong>Conclusions: </strong>Serum OxPLs and eNOS in the acute stage of KD may be involved in the development of CAL in children with KD, and therefore, they may be used as the biomarkers to predict CAL in these children.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 8","pages":"829-834"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国当代儿科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1